Mitochondria: More Than Just Powerhouses of the Cell
In this episode of the Drive podcast, Dr. Peter Attia speaks with renowned scientist Dr. Navdeep Chandel about the complex world of mitochondria. The conversation demystifies the hype around this organelle, delving into its three core functions:
- Traditional View: ATP Production and Anabolism: Mitochondria are the primary producers of ATP (the cell's energy currency) and also supply building blocks (metabolites) for lipids, nucleotides, and proteins.
- Revolutionary New Function 1: Communication via Signals: Mitochondria actively send signals to the cell, for example, in the form of hydrogen peroxide (H₂O₂) . Once dismissed as harmful, low doses of H₂O₂ are now recognized as an important signal for immune function and cell differentiation. Metabolites like alpha-ketoglutarate even control epigenetics (e.g., DNA demethylation).
- Revolutionary New Function 2: Immune Response and Cell Death: Mitochondrial DNA or RNA can activate the immune system, similar to foreign pathogens. Furthermore, the release of cytochrome c from the mitochondrion is the central signal for programmed cell death (apoptosis).
Mitochondrial Dysfunction: A Paradox?
Contrary to popular belief, Dr. Chandel is skeptical that declining ATP production is the primary cause of normal aging. Three crucial points:
- Large Reserve Capacity: More than 70% of mitochondrial function must be lost before symptoms appear – similar to a car that, despite a lower top speed, is still fully functional in city traffic.
- Mutation Studies: Mouse models with massively increased mitochondrial DNA mutations (10-fold above normal) do not show a typical aging phenotype. Aging seems to stem more from miscommunication (signal problems) rather than a lack of energy or building materials.
- Measurability: The only good, albeit rough, test is maximal oxygen uptake (VO₂max) under stress (e.g., cycle ergometry). From Dr. Chandel's perspective, blood, urine, or breath tests are not valid as they only provide a snapshot (steady state) and not actual functional capacity (flux).
Metformin: A Renaissance Drug with a Focus on the Gut
Metformin, an old diabetes drug, is discussed as a potential "geroprotector." Dr. Chandel presents new research findings:
- Mechanism of Action: Metformin inhibits Complex I of the respiratory chain. In the gut, this leads to increased glucose uptake, which lowers blood sugar levels – an important health effect.
- The Gut as a Key Organ: Metformin's effectiveness depends critically on organic cation transporters that bring it into the cell. Dr. Chandel shows that the primary site of action is not the liver but the gut. There, it inhibits mitochondrial function, leading to positive effects on blood sugar, gut microbiome, and inflammation markers (reducing IL-6).
- Potential in Cancer: In tumors possessing the necessary transporter, metformin could work by inhibiting cell growth (anabolism). This mechanism might also suppress the formation of clonal hematopoiesis (CHIP) , a risk factor for cardiovascular disease.
- Practice for Healthy Individuals: Dr. Chandel considers taking metformin himself, primarily for its anti-inflammatory effects, e.g., against air pollution. He recommends taking it 30 minutes before a meal and advises supplementation with Vitamin B12 and possibly citrulline (e.g., from watermelon) to prevent potential deficiencies. He warns against using the expensive and unregulated berberine instead, as it acts very similarly.
Supplement Jungle: Where is the Evidence?
Dr. Chandel critically examines many touted "mitochondrial boosters" against his three principles: 1. Where does it go? 2. What is its molecular target? 3. Does it work in humans?
- Urolithin A: Is barely detectable in the body and is rapidly metabolized. It has no clear target. Data is too thin for a general recommendation.
- Alpha-Ketoglutarate: Has a clear target (epigenetics) and promising but yet-to-be-completed human studies. More of a niche candidate.
- NAD Precursors (NR, NMN): NAD levels decline with age, but whether it becomes limiting is unclear. Human studies (e.g., ITP) were negative. More suitable for specific applications (e.g., liver regeneration).
- CoQ10, L-Carnitine, Citrulline: Levels are sufficient in a normal, healthy diet. CoQ10 can be beneficial during statin therapy, but the evidence is inconsistent.
- Methylene Blue & Red Light Therapy: Both have potential targets in Complex IV (cytochrome c oxidase), but clinical evidence is weak. Red light therapy shows significant effects for skin rejuvenation and, surprisingly, for lowering blood sugar (through improved glucose uptake). Hyperbaric oxygen therapy is not considered beneficial for general health.
Conclusion & Outlook
Dr. Chandel advocates for a new way of thinking: Instead of viewing mitochondria only as ATP suppliers, we must understand their signaling functions. The biggest challenge is the lack of fundamental funding for metabolism research compared to genomics. A "moonshot for metabolism" could yield groundbreaking therapies for aging, cancer, and inflammation. Metformin currently appears to be the most promising and best-studied "geroprotective" agent among the substances discussed.
Note: This podcast is for general information only and does not replace medical advice. For health-related questions, please consult your physician.